Skip to main content

Table 7 Estimated gametocyte carriage rates (GCR)

From: Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity

 

All

(N = 2027)

Thailand

(N = 922)

The Gambia

(N = 681)

Tanzania

(N = 424)

GCR (%) after 7 days (95% CI)

Overall

54 (52–56)

34 (31–37)

65 (61–69)

71 (66 – 75)

Gametocytaemia on enrolment

    

   No

53 (50–55)

32(28–36)

71 (66–75)

69 (64–75)

   Yes

58 (39–45)

40 (35–45)

77 (71–82)

75 (66–82)

Treatment

    

A

33 (30–36)

24(20–28)

54 (48–60)

26 (5–53)

C-F

62 (58–65)

50 (44–55)

81 (63–91)

73 (68–78)

G-H

85 (71–88)

 

86 (82–89)

66 (45–80)

GCR (%) after 14 days (95% CI)

Overall

41 (38–43)

19 (16–22)

65 (61–69)

57 (51–63)

Gametocytaemia on enrolment

    

   No

42 (39–45)

18 (14–21)

71(66–75)

53(46–60)

   Yes

41(37–45)

23 (18–28)

58 (51–64)

65 (54–74)

Treatment 1

    

   A

18(15–21)

9 (7–12)

38 (32–45)

13(1–42)

   C-F

47(43–51)

34 (29–40)

81 (63–91)

60 (54–66)

   G-H

80 (75–84)

 

83 (77–87)

38 (18–58)

  1. 1 treatments groups are defined as: A: artemisisnin combination alone or with other treatments;
  2. C-F: other monotherapies (see Table 1); G-H: SP alone or SP with chloroquine.